###begin article-title 0
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1; Slc19a1</italic>
Microarray analysis of E9.5 reduced folate carrier (RFC1; Slc19a1) knockout embryos reveals altered expression of genes in the cubilin-megalin multiligand endocytic receptor complex
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 284 290 <span type="species:ncbi:10090">murine</span>
The reduced folate carrier (RFC1) is an integral membrane protein and facilitative anion exchanger that mediates delivery of 5-methyltetrahydrofolate into mammalian cells. Adequate maternal-fetal transport of folate is necessary for normal embryogenesis. Targeted inactivation of the murine RFC1 gene results in post-implantation embryolethality, but daily folic acid supplementation of pregnant dams prolongs survival of homozygous embryos until mid-gestation. At E10.5 RFC1-/- embryos are developmentally delayed relative to wildtype littermates, have multiple malformations, including neural tube defects, and die due to failure of chorioallantoic fusion. The mesoderm is sparse and disorganized, and there is a marked absence of erythrocytes in yolk sac blood islands. The identification of alterations in gene expression and signaling pathways involved in the observed dysmorphology following inactivation of RFC1-mediated folate transport are the focus of this investigation.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 913 917 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 917 921 908 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Affymetrix microarray analysis of the relative gene expression profiles in whole E9.5 RFC1-/- vs. RFC1+/+ embryos identified 200 known genes that were differentially expressed. Major ontology groups included transcription factors (13.04%), and genes involved in transport functions (ion, lipid, carbohydrate) (11.37%). Genes that code for receptors, ligands and interacting proteins in the cubilin-megalin multiligand endocytic receptor complex accounted for 9.36% of the total, followed closely by several genes involved in hematopoiesis (8.03%). The most highly significant gene network identified by Ingenuitytrade mark Pathway analysis included 12 genes in the cubilin-megalin multiligand endocytic receptor complex. Altered expression of these genes was validated by quantitative RT-PCR, and immunohistochemical analysis demonstrated that megalin protein expression disappeared from the visceral yolk sac of RFC1-/- embryos, while cubilin protein was widely misexpressed.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
Inactivation of RFC1 impacts the expression of several ligands and interacting proteins in the cubilin-amnionless-megalin complex that are involved in the maternal-fetal transport of folate and other nutrients, lipids and morphogens such as sonic hedgehog (Shh) and retinoids that play critical roles in normal embryogenesis.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1224 1225 1224 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1436 1437 1436 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 989 996 <span type="species:ncbi:3847">soybean</span>
Folate and vitamin B12 are essential vitamins derived from various food sources that play an important role in erythropoiesis, DNA biosynthesis, and embryogenesis. Nutritional deficiencies or genetic variations that impact folate and/or vitamin B12 homeostasis may result in megaloblastic anemia [1], and failure of maternal-fetal transport of these nutrients has been shown to adversely impact normal embryogenesis [2-5]. Folate is a vitamin derived from plant sources that consists of a pteridine ring structure attached to a para-aminobenzoic acid side chain. Tetrahydrofolate, the reduced form of folate, functions as an important co-factor for donating or accepting methyl groups. Adequate levels of folate for the incorporation of single carbon groups into purine, or methylation of deoxyuridylate to form thymidylate, are necessary for DNA biosynthesis. Vitamin B12, also known as cobalamin, is another important vitamin that is obtained from dietary sources such as meat, fish and soybean. Folate and cobalamin metabolism are highly interdependent. In mammals, cobalamin functions as a co-enzyme for methionine synthase, which is involved in the tetrahydrofolate-dependent methylation of homocysteine to methionine [6]. According to the "folate-trap hypothesis", cobalamin deficiency results in 'trapping' of tetrahydrofolate, producing a functional folate deficiency that leads to impaired erythropoiesis and DNA biosynthesis [7].
###end p 9
###begin p 10
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1005 1006 1005 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
The primary mechanisms for folate delivery into the cell are through (1) carrier-mediated (reduced folate carrier; RFC1) or (2) receptor-mediated (folate receptor; Folr1) processes. These two transport systems are distinguished by their unique patterns of tissue expression, differing protein structures, specificities for oxidized vs. reduced folates, and divergent mechanisms for transmembrane transport of folates [8]. As mammalian cells are not capable of synthesizing folates de novo, these two transport systems play a critical role in mediating folate uptake for the biosynthesis of purines, pyrimidines, and certain amino acids that are necessary for cell survival and proliferation. It has recently been discovered that megalin, a large multiligand endocytic receptor of the low density lipoprotein receptor family, is capable of binding and mediating uptake of the soluble form of the GPI-anchored folate receptor Folr1, providing yet another pathway for the cellular internalization of folate [9].
###end p 10
###begin p 11
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1176 1178 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The principal route of folate transport into mammalian cells is via the reduced folate carrier (RFC1), a bidirectional transporter characterized by twelve transmembrane domains [8,10]. RFC1 preferentially transports reduced folates, such as N5-methyltetrahydrofolate or N5-formyltetrahydrofolate, which are anionic at physiological pH. It functions as a facilitative anion exchanger, capable of transporting anionic folates into the cell via a co-transport system in which the uphill transport of folate is coupled to the downhill efflux of organic phosphates or sulfates [8,11]. Folate uptake into intestinal cells is markedly increased at pH 5.5 relative to pH 7.4 [12,13], suggesting that RFC1-mediated folate uptake is highly dependent on acidic extracellular pH. In adult tissues, RFC1 expression is observed in the brush border of the small and large intestine, and in the basolateral membrane of renal tubular epithelium, as well as in hepatocytes, choroid plexus, and the retinal pigment epithelium [14]. During development, RFC1 is highly expressed in multiple tissue types, including the placenta and yolk sac, neural tube, craniofacial region, limb buds and heart [14,15].
###end p 11
###begin p 12
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 203 207 203 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 219 228 219 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 260 264 260 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
We have recently characterized the role of RFC1 during embryonic development in a mouse model in which RFC1 was inactivated by homologous recombination [16]. Without maternal folate supplementation, RFC1-/- embryos die in utero shortly after implantation. RFC1-/- embryos harvested from dams receiving low doses of supplemental folic acid (25 mg/kg/day SQ), survive to mid-gestation (E10.5), but are developmentally delayed, and display multiple malformations, including severe neural tube defects, craniofacial, heart, and limb abnormalities. Examination of the placenta reveals that embryolethality is due to a failure of chorioallantoic fusion. The fetal vasculature appears to form normally, but there is a pronounced absence of erythropoiesis, with very few nucleated fetal red blood cells present in either the fetal blood vessels or the yolk sac blood islands. Maternal folate supplementation with 50 mg/kg/day results in survival to term of 22% of the RFC1 mutants, although the surviving fetuses present with multiple malformations of the craniofacies, lungs, heart and skin.
###end p 12
###begin p 13
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC</italic>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
The reduced folate carrier gene has previously been inactivated in a mouse model [17] through targeted disruption of a large part of exon 3. Zhao [17] reported that the RFC1-/- embryos died in utero before E9.5, but near-normal development could be sustained by supplementing pregnant RFC+/- dams with daily doses of 1 mg folic acid SQ. Approximately 10% of the partially rescued RFC1-/- pups were live-born, but all died within 12 days post-partum. In the Zhao [17]RFC1 knockout mouse model, perinatal lethality was attributed to a marked absence of erythropoiesis in bone marrow, spleen, and liver. Our recent findings indicate that inactivation of RFC1 results in congenital malformations of the heart and lungs that undoubtedly contribute to the failure of RFC1 mutants to survive postnatally.
###end p 13
###begin p 14
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 315 319 315 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
The purpose of this report is to identify alterations in biochemical and/or molecular genetic pathways that may play a role in the abnormal embryonic morphogenesis observed following inactivation of RFC1. In the current study, the gene expression profiles of whole E9.5 RFC1-/- embryos were compared to that of RFC1+/+ littermates harvested from pregnant dams receiving daily low dose (25 mg/kg/day S.Q.) folate supplementation. Our microarray analysis shows that in the absence of functional RFC1, the expression profiles of numerous transcription factors, as well as several genes involved in hematopoiesis, ion homeostasis, and genes encoding for receptors and/or ligands in the cubilin-megalin multiligand endocytic receptor complex are significantly altered. Follow-up quantitative RT-PCR validation confirms alterations in the expression profiles of several ligands and interacting proteins in the cubilin-megalin complex that are involved in nutrient transport of vitamins and lipids to the developing embryo.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Microarray analysis
###end title 16
###begin p 17
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 934 935 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1223 1227 1223 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1227 1231 1227 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1255 1259 1255 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1259 1263 1259 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
In the microarray analysis of E9.5 RFC1-/- embryos vs. RFC1+/+ embryos, the expression patterns of 783 genes were found to be significantly altered at the 0.001 level. However, when looking at the false discovery rate (FDR), only 288 genes (probe sets) were significantly altered at the 0.001 level. Several of the probe sets represent alternate transcripts for the same gene. Taking this into account, 250 unique genes were identified as differentially expressed in the microarray analysis. Of these, 200 represent known genes, while 50 are ESTs or unknowns. The 12 known genes in our data set that have been identified as cell surface receptors, ligands, or interacting proteins in the cubilin-megalin multiligand endocytic receptor complex are listed in Table 1, and the complete set of 200 known genes that were differentially expressed following statistical analysis of the microarray data are also provided [see Additional file 1]. The genes have been categorized according to ontology groups, and the file contains the accession number, gene symbol, gene name, and the mean fold change for the expression level of each gene. The fold-change represents the value for the comparison of level of gene expression in the RFC1-/- embryos relative to the RFC1+/+ embryos. (The data discussed in this publication have also been deposited in NCBIs Gene Expression Omnibus [18] and are accessible to the public through GEO Series accession number GSE10659).
###end p 17
###begin p 18
Microarray gene list: Multiligand endocytic receptor complex
###end p 18
###begin title 19
Distribution of gene ontology groups
###end title 19
###begin p 20
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
A pie chart showing the relative distribution (percentage) of the gene ontology groups identified in the microarray analysis of the RFC1-/- vs. RFC1+/+ embryos is shown in Figure 1. The largest ontology group of known genes that was altered included several families of transcription factors (13.04%), followed by genes involved in transport functions (ion, lipid, carbohydrate) (11.37%). Genes that code for receptors, ligands and interacting proteins in the cubilin-megalin multiligand endocytic receptor complex account for 9.36% of the total, followed closely by several genes involved in hematopoiesis (8.03%).
###end p 20
###begin p 21
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of gene ontology groups</bold>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 175 179 175 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 187 191 187 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Distribution of gene ontology groups. A pie chart showing the relative distribution (percentage) of the gene ontology groups identified in the microarray analysis of E9.5 RFC1-/- vs. RFC1+/+ embryos is shown. A complete list of the genes within each of these gene ontology groups that were differentially expressed following statistical analysis of the microarray data is provided in [Additional file 1].
###end p 21
###begin title 22
Ingenuity Pathway Analysis
###end title 22
###begin p 23
###xml 194 195 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 730 759 721 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1, Shh, Timd2, Myo6, Dab2</italic>
###xml 798 851 789 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(Tf*, LgalS3, Alb, Gif, Amn, Lrp2, Lrpap1*, ScgB1A1) </italic>
The most highly significant gene network identified in the Ingenuity Pathway analysis (Ingenuitytrade mark Systems, Inc., Mountain View, CA) of our Affymetrix microarray data is shown in Figure 2. Based on new information available in the recent literature (interactions not yet reported in the latest release of the Ingenuity Knowledge Base), we identified an additional 11 genes of interest that were placed into this network. These additional genes are represented by 11 custom nodes and edges. In the original "Network 1" of the Ingenuity Pathway Analysis, 32 of the 34 genes that appear were statistically up or down-regulated on our microarray analysis, giving it a score of 55. With the addition of the custom nodes/edges (Folr1, Shh, Timd2, Myo6, Dab2) and nodes from the Cubn neighborhood-(Tf*, LgalS3, Alb, Gif, Amn, Lrp2, Lrpap1*, ScgB1A1) {*genes that already appear in the default "Network 1"} 34 of the 46 genes in the custom network were found to be significant. Many of the key genes highlighted in this top network are members of the ontology group that includes receptors, ligands and interacting proteins found in the cubilin-megalin multiligand endocytic receptor complex. This complex became the focus of further studies due to its important role in the uptake of folate and other vitamins, lipids, and nutrients essential for embryonic development.
###end p 23
###begin p 24
###xml 0 40 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ingenuity&#8482; Pathway gene network</bold>
Ingenuitytrade mark Pathway gene network. The most highly significant gene network identified in the Ingenuitytrade mark Pathway analysis of our Affymetrix microarray data is shown. An additional 11 'custom' genes were placed into this network based on new information available in the recent literature. Many of the key genes highlighted in this top network are members of the ontology group that includes receptors, ligands and interacting proteins found in the cubilin-megalin multiligand endocytic receptor complex. The networks are displayed graphically as nodes (genes/gene products) and edges (the biological relationships between the nodes). The intensity of the node color indicates the degree of up- (red) or down- (green) regulation in gene expression in our microarray analysis. Nodes are displayed using various shapes that represent the functional class of the gene product. Edges are displayed as a direct interaction (solid line) or as an indirect/unknown interaction (dashed line). The nodes have also been arranged to show the location of the gene/gene product with respect to cellular or subcellular localization (e.g. plasma membrane, cytoplasm, nucleus, etc.).
###end p 24
###begin title 25
Cubilin-megalin multiligand endocytic receptor complex
###end title 25
###begin p 26
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1306 1308 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1573 1575 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 450 453 <span type="species:ncbi:10116">rat</span>
###xml 579 584 <span type="species:ncbi:10090">mouse</span>
###xml 1091 1096 <span type="species:ncbi:10090">mouse</span>
A diagram of the structure of the cubilin-amnionless-megalin multiligand receptor endocytic complex is shown in Figure 3[19]. Megalin and cubilin are two multifunctional endocytic receptors that act in concert in certain tissues to mediate the uptake of a variety of lipoproteins and vitamin-carrier complexes [19-21]. Striking similarities in temporal and spatial expression patterns of megalin and cubilin have been described in mid-late gestation rat embryos [22], although differential patterns of expression have also been reported during early embryonic development in the mouse [23]. Megalin (Lrp2) is a low-density lipoprotein receptor-related protein that is co-expressed with cubilin in many absorptive epithelia, including the neuroepithelium and yolk sac of developing embryos. Several studies indicate a critical role for megalin in normal embryogenesis [24]. Megalin has been shown to bind and internalize multiple ligands, including the soluble folate binding protein (Folr1), and sonic hedgehog (Shh), among others [19,25-29]. Lack of megalin receptor function in a knockout mouse model results in abnormalities of the kidneys, lungs, central nervous system and craniofacies, and megalin-deficient pups die perinatally within the first few minutes of life due to respiratory insufficiency [30]. Conditional inactivation of megalin in the neuroepithelium has been shown to result in a loss of Shh expression in the ventral telencephalon [31], indicating that megalin-mediated uptake of Shh in the neuroepithelium is critical for early forebrain development [32].
###end p 26
###begin p 27
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cubilin-megalin multiligand endocytic receptor complex</bold>
###xml 1571 1573 1571 1573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
Cubilin-megalin multiligand endocytic receptor complex. A cartoon diagram of the structure of the cubilin-amnionless-megalin multiligand receptor endocytic complex [19] is shown. Megalin is a cell-surface receptor/transporter consisting of a large extracellular region, a single transmembrane domain, and a C-terminal cytoplasmic tail. The extracellular domain of megalin contains four clusters of lipoprotein receptor ligand-binding repeats (blue), growth factor repeats, an EGF repeat, and YWTD spacer regions. The second cluster of ligand-binding repeats has been identified as a common binding site for several ligands including apolipoprotein E (Apo E), apolipoprotein M (Apo M), retinol binding protein (Rbp), and transthyretin (Ttr). Megalin also binds the soluble form of the folate receptor (Folr1), and the morphogen sonic hedgehog (Shh). The cytoplasmic tail of megalin binds Dab2, a cytosolic adapter protein important for megalin-mediated endocytosis, and Dab2 binds and recruits Myo6 to clathrin-coated vesicles. The receptor-associated protein (Lrpap1; RAP) binds both megalin and cubilin. Cubilin is a peripheral membrane receptor comprised of a short amino terminal, eight EGF type domains, and 27 CUB domains (green). The amino-terminal end of cubilin is attached to the extracellular part of amnionless (Amn), and amnionless provides the transmembrane domain necessary for the anchoring and endocytic trafficking of cubilin. Cubilin ligands include transferring (Trf), albumin, hemoglobin, apolipoprotein A1 (ApoA1), and intrinsic factor (IF)-vitamin B12.
###end p 27
###begin p 28
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 629 639 629 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amnionless</italic>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 834 838 <span type="species:ncbi:10116">rats</span>
###xml 885 890 <span type="species:ncbi:10090">mouse</span>
###xml 995 1001 <span type="species:ncbi:10090">murine</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
Cubilin (gp280) functions as an endocytic receptor for the intrinsic factor-cobalamin complex in the intestine, and as a receptor for apolipoprotein A1 and albumin reabsorption in the kidney proximal tubules and visceral yolk sac [33]. Cubilin is a peripheral membrane receptor comprised of a short amino terminal amphipathic helix, eight EGF type domains, and 27 amino acid modules known as CUB domains [34]. Although cubilin lacks a classic transmembrane domain and cytoplasmic tail, the amino-terminal end is necessary for membrane anchoring [35]. The amino-terminal region of cubilin is attached to the extracellular part of amnionless, which provides the transmembrane domain necessary for anchoring and endocytic trafficking of cubilin [36]. Antibodies directed against cubilin have been reported to have teratogenic effects in rats [37], and targeted disruption of cubilin in a mouse model reveals an essential role for this receptor in embryogenesis [38]. Homozygous inactivation of the murine cubilin gene results in embryolethality between E7.5 - E13.5. Cubilin knockout mice are characterized by defects in certain mesodermally-derived tissues, including failure of somite formation and abnormalities of the yolk sac blood islands and visceral endoderm [38].
###end p 28
###begin p 29
###xml 195 266 195 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cubilin, Amnionless, Megalin, Receptor-Associated Protein (RAP; Lrpap1)</italic>
###xml 272 291 272 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Disabled homolog-2 </italic>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 483 489 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1 </italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 503 507 503 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 687 706 687 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cubilin, amnionless</italic>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 824 828 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 828 832 828 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 966 974 966 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">megalin </italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
A comparative overview of the developmental phenotype of mice with genetically engineered deletions in critical components of the cubilin-megalin multiligand endocytic receptor complex including Cubilin, Amnionless, Megalin, Receptor-Associated Protein (RAP; Lrpap1), and Disabled homolog-2 is provided [see Additional file 2]. The phenotypes of these mutants are compared to the developmental anomalies observed following genetically engineered deletions in the folate transporters Folr1 and RFC1. RFC1-/- embryos on low dose maternal folate supplementation (such as those examined in the microarray analysis) display certain phenotypic traits in common with the more severely affected cubilin, amnionless, and Dab2 knockouts, including failure of chorioallantoic fusion and defects in mesoderm-derived structures, whereas RFC1-/- embryos that survive to term following high dose maternal folate supplementation display a range of malformations more similar to the megalin knockout mutants.
###end p 29
###begin title 30
Quantitative real-time PCR validation
###end title 30
###begin p 31
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 718 757 718 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cubn, ApoA1, Amn, Trf, Timd2, Rbp4, Ttr</italic>
###xml 796 804 796 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(Folr1) </italic>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 846 850 846 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 879 883 879 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1018 1036 1018 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lrp2, Lrpap1, Dab2</italic>
###xml 1041 1044 1041 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
Genes in the cubilin-megalin multiligand endocytic receptor complex identified in the Affymetrix microarray analysis, Ingenuity Pathway analysis, or through additional information available in the literature were selected for further expression analysis by quantitative RT-PCR (qRT-PCR). The twelve genes selected for qRT-PCR validation of alterations in gene expression are listed along with a description of their function, and the ABI primer/probe sets used for these experiments [see Additional file 3]. Figure 4 and Table 2 list the results of the qRT-PCR analysis, including p-values, and a graph of the relative levels of expression of the selected genes in the multiligand receptor endocytic complex is shown. Cubn, ApoA1, Amn, Trf, Timd2, Rbp4, Ttr, and the GPI-anchored folate receptor (Folr1) are significantly upregulated in E9.5 RFC1-/- embryos relative to E9.5 RFC1+/+ littermates (*p < .05; **p < .01). However, the qRT-PCR analysis did not detect statistically significant changes in the expression of Lrp2, Lrpap1, Dab2, or Shh. Error bars represent SEM values.
###end p 31
###begin p 32
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative RT-PCR relative gene expression levels</bold>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppil2 </italic>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dctn6</italic>
###xml 764 1088 764 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cubilin (Cubn), Apolipoprotein A1 (ApoA1), Amnionless (Amn), Transferrin (Trf), T-cell immunoglobin and mucin domain containing 2 (Timd2), Megalin (Lrp2), Lipoprotein receptor-associated protein 1 (Lrpap1), Disabled (Dab2), Folate Receptor (Folr1), Retinol Binding Protein 4 (Rbp4), Sonic Hedgehog (Shh), Transthyretin (Ttr)</italic>
Quantitative RT-PCR relative gene expression levels. The results of the quantitative RT-PCR validation experiments are shown in the graph. Genes were selected for the RT-PCR analysis based on the results of the microarray analysis, or because of their presence in the cubilin-megalin multiligand endocytic receptor complex. The red bars on the left represent the fold change in the expression of cubilin and cubilin-related genes and the blue bars on the right represent the fold change in the expression of megalin and megalin-related genes relative to the expression of the housekeeping genes Ppil2 and Dctn6. (*p < .05; **p < .01) Error bars represent SEM values. Gene symbols, relative expression levels and p values are provided in the corresponding Table 2. Cubilin (Cubn), Apolipoprotein A1 (ApoA1), Amnionless (Amn), Transferrin (Trf), T-cell immunoglobin and mucin domain containing 2 (Timd2), Megalin (Lrp2), Lipoprotein receptor-associated protein 1 (Lrpap1), Disabled (Dab2), Folate Receptor (Folr1), Retinol Binding Protein 4 (Rbp4), Sonic Hedgehog (Shh), Transthyretin (Ttr).
###end p 32
###begin p 33
qRT-PCR Gene Expression Levels
###end p 33
###begin p 34
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1 </italic>
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">megalin </italic>
###xml 311 317 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1 </italic>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1 </italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 612 615 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC</italic>
###xml 630 634 630 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 720 727 720 727 <underline xmlns:xlink="http://www.w3.org/1999/xlink">cubilin</underline>
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>cubilin</underline></italic>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 742 746 742 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn </italic>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn </italic>
###xml 1156 1167 1156 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amnionless </italic>
###xml 1275 1286 1275 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amnionless </italic>
###xml 1346 1350 1346 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1350 1354 1350 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Although neither Folr1 nor megalin gene expression made the cut-off for statistical significance on our microarray analysis, we included them in our qRT-PCR analysis because of their presence in the multiligand endocytic receptor complex, and their important role in nutrient delivery to the developing embryo (Folr1 was upregulated 5.3 fold, p < .0003 on the microarray analysis, but did not make the cut-off for the FDR level). qRT-PCR results demonstrated no significant difference in message levels of megalin between the two groups, but a 10-fold increase in Folr1 expression was detected (p < .017) in RFC1-/-relative to RFC+/+ littermates. RT-PCR validation also demonstrates a highly significant upregulation of cubilinmessage in RFC1-/- embryos (77-fold, p < .002). Amn mediates cell-surface localization and endocytic function of cubilin in the visceral endoderm [39]. Amn did not make the list of 288 genes identified as statistically significant in our microarray analysis using the stringent cut-off of 0.001 for adjusted p-values (p = .00109). However, due to its critical role in cubilin expression and function, we chose to further analyze amnionless gene expression levels by quantitative RT-PCR. Our results show that, similar to cubilin, the expression of amnionless was highly significantly upregulated (75-fold; p < .002) in RFC1-/- embryos.
###end p 34
###begin title 35
Immunohistochemistry
###end title 35
###begin p 36
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
During normal embryonic development, megalin and cubilin are highly expressed in the visceral endoderm (VE) and visceral yolk sac (VYS), and function cooperatively in the maternal-fetal transfer of multiple nutrients and morphogens. The VE is a polarized epithelial tissue that surrounds the developing epiblast. The apical surface of the VE faces maternal tissues, and contains numerous microvilli that function to absorb nutrients from the maternal environment [40]. Additional roles in patterning anterior-posterior polarity of the early embryo, correct positioning of the primitive streak, induction of blood precursors, and forebrain development have been ascribed to the anterior VE [41-43]. Following implantation, the VE surrounding the epiblast differentiates to form the VYS. The VYS continues to play a critical role in maternal-fetal nutrient and waste exchange prior to establishment of the chorioallantoic placenta [44].
###end p 36
###begin p 37
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 260 262 260 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5A</bold>
###xml 274 276 274 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5C</bold>
###xml 289 291 289 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5E</bold>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 368 372 368 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 473 477 473 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 486 488 486 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5B</bold>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 571 573 571 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5D</bold>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 661 665 661 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 773 775 773 775 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5F</bold>
Immunohistochemical expression of cubilin, megalin and Folr1 protein in E9.5 RFC1+/+ and RFC1-/- embryos and extra-embryonic membranes was examined. Expression of cubilin, megalin and Folr1 protein in the visceral yolk sac (VYS) is shown in Figure 5. Cubilin (5A), megalin (5C) and Folr1 (5E) protein are all highly expressed on the apical side of the VYS in E9.5 RFC1+/+ embryos (brown staining). Cubilin is also highly expressed on the apical side of the VYS in E9.5 RFC1-/- embryos (5B). Megalin expression, however, is completely absent from the VYS of RFC1 mutants (5D). Folr1 protein expression is absent from the apical plasma membrane of the VYS in RFC1-/- embryos, but demonstrates increased expression in the endothelial cell layer of the yolk sac blood islands (5F).
###end p 37
###begin p 38
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cubilin, megalin and Folr1 protein expression in VYS</bold>
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 278 282 278 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 393 394 393 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 491 492 491 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 673 674 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
Cubilin, megalin and Folr1 protein expression in VYS. Expression of cubilin, megalin and Folr1 protein in the visceral yolk sac is shown in Figure 5. Cubilin (A), megalin (C) and Folr1 (E) protein are all highly expressed on the apical side of the visceral yolk sac in E9.5 RFC1+/+ embryos. Cubilin is also highly expressed on the apical side of the visceral yolk sac in E9.5 RFC1-/- embryos (B). Megalin expression, however, is completely absent from the visceral yolk sac of RFC1 mutants (D). Folr1 protein expression is absent from the apical plasma membrane of the VYS, but demonstrates increased expression in the endothelial cell layer of the yolk sac blood islands (F).
###end p 38
###begin p 39
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 245 247 245 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6A</bold>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 273 277 273 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 310 314 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 373 375 373 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6B</bold>
###xml 411 413 411 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6B</bold>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 665 669 665 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 906 908 906 908 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C</bold>
###xml 1009 1011 1009 1011 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C</bold>
###xml 1013 1015 1013 1015 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6E</bold>
###xml 1037 1041 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1041 1044 1041 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1056 1060 1056 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1060 1064 1060 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1156 1164 1156 1164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6D; 6G; </bold>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1260 1264 1260 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1273 1275 1273 1275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6F</bold>
###xml 1457 1461 1457 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1461 1465 1461 1465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1499 1511 1499 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">surrounding </italic>
###xml 1526 1532 1526 1532 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6D, 6H</bold>
###xml 1604 1609 1604 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1619 1621 1619 1621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6I</bold>
###xml 1782 1787 1782 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1903 1908 1903 1908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1917 1919 1917 1919 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6J</bold>
###xml 623 631 <span type="species:ncbi:405018">cardinal</span>
Expression of cubilin and megalin protein in the neuroepithelium is shown in Figure 6. Megalin expression is observed in the retinal pigment epithelium, cells lining the otic vesicle, and exclusively on the apical side of neuroepithelial cells (6A; red arrows) in E9.5 RFC1+/+ embryos (brown staining). In RFC1-/- embryos, however, megalin is expressed on both the apical (6B; red arrows) and basolateral side (6B; purple arrowheads) of the neuroepithelium. Positive staining for megalin is also observed in the surface ectoderm, notochord, pericardium, and endothelial cells lining vascular structures (primary head veins/cardinal veins and vitelline vein) of RFC1+/+ embryos, but megalin staining is faint or absent in the (hindbrain) notochord and endothelium of similar vascular structures in RFC1 mutant embryos (not shown). Similar to megalin, cubilin expression is observed in the surface ectoderm (6C; black arrows), retinal pigment epithelium, otic vesicle, and apical side of neuroepithelial cells (6C; 6E; red arrows) in E9.5 RFC1+/+embryos. In RFC1-/- embryos, however, cubilin is misexpressed on the basolateral side of neuroepithelial cells (6D; 6G; purple arrowheads), Discrete, positive staining for cubilin is observed in the notochord of RFC1+/+ embryos (6F, yellow arrow). In contrast, the expression of cubilin protein appears to be highly upregulated and widespread throughout the (sparse) mesenchyme underlying the neural tube (NT) of RFC1-/- embryos, especially in the region surrounding the notochord (6D, 6H, yellow arrow). Cubilin staining is present in the pericardium of both RFC1 wildtype (6I; black arrowhead) and mutant embryos. Although there are a few cells that stain positive for cubilin in the trabeculae of the common ventricular chamber in the RFC1 wildtype heart, cubilin expression is dramatically upregulated throughout the myocardium of the developing heart in RFC1 mutants (6J).
###end p 39
###begin p 40
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cubilin and megalin protein expression in E9.5 embryos</bold>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 151 155 151 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 464 467 464 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C </bold>
###xml 471 474 471 474 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6D </bold>
###xml 582 584 582 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6A</bold>
###xml 586 588 586 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6B</bold>
###xml 590 592 590 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6E</bold>
###xml 598 600 598 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6G</bold>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 922 924 922 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6A</bold>
###xml 976 978 976 978 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6B</bold>
###xml 1018 1020 1018 1020 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6B</bold>
###xml 1067 1072 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1166 1171 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1189 1191 1189 1191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C</bold>
###xml 1193 1195 1193 1195 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6E</bold>
###xml 1280 1285 1280 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1306 1308 1306 1308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6D</bold>
###xml 1310 1312 1310 1312 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6G</bold>
###xml 1401 1405 1401 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1405 1409 1405 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1418 1420 1418 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C</bold>
###xml 1494 1496 1494 1496 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6C</bold>
###xml 1498 1500 1498 1500 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6F</bold>
###xml 1587 1591 1587 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1591 1595 1591 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1619 1621 1619 1621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6D</bold>
###xml 1709 1711 1709 1711 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6H</bold>
###xml 1815 1820 1815 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1830 1832 1830 1832 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6I</bold>
###xml 1855 1860 1855 1860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1908 1910 1908 1910 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6J</bold>
###xml 2136 2141 2136 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 2149 2151 2149 2151 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6J</bold>
###xml 2298 2303 2298 2303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 2375 2380 2375 2380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 2431 2435 2431 2435 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LV: </bold>
###xml 2232 2240 <span type="species:ncbi:405018">cardinal</span>
Cubilin and megalin protein expression in E9.5 embryos. Immunohistochemical staining was performed on transverse sections through E9.5 RFC1+/+ and RFC1-/- embryos in order to examine the relative expression and distribution of megalin and cubilin protein. The level and plane of the sections shown in Figure 6 is illustrated by the line drawn through the embryo shown in the upper left hand corner. The red boxes drawn over the neuroepithelium of embryos shown in 6C and 6D (4x magnification) indicate the orientation of the higher magnification panels (40x magnification) shown in 6A, 6B, 6E, and 6G; the apical surface (ventricular side) of the neuroepithelial cells is shown on the right of these panels, and the basolateral, or mesenchymal side of the neuroepithelial cells is shown on the left side of the panels. Megalin is expressed exclusively on the apical side of neuroepithelial cells in RFC1 wildtype embryos (6A; red arrows), but is expressed on both the apical (6B; red arrows) and the basolateral side (6B; purple arrowheads) of the neuroepithelium in RFC1 mutants. Cubilin expression is also restricted to the apical side of neuroepithelial cells in RFC1 wildtype embryos (6C, 6E; red arrows), but is misexpressed on the basolateral side of the neuroepithelium in RFC1 nullizygous embryos (6D, 6G; purple arrowheads). Staining for cubilin protein is visible in the surface ectoderm of RFC1+/+ embryos (6C; black arrows), and discrete staining is also observed in the notochord (6C, 6F; yellow arrow). Cubilin expression is highly upregulated in the cranial mesenchyme of RFC1-/- embryos (shown in panel 6D) relative to wildtype littermates, especially in the region surrounding the notochord (6H; yellow arrow). Staining for cubilin protein is visible in the mesothelial cells of the pericardium of RFC1 wildtype (6I; black arrowhead) and RFC1 mutant embryos (not visible in section shown in 6J), and although there are a few cells that stain positive for cubilin in the trabeculae of the common ventricular chamber in the wildtype embryo, cubilin expression is dramatically upregulated throughout the myocardium of the RFC1 mutant (6J). Normal morphology of the primary head vein/cephalic extension of the anterior cardinal vein (**) and the third branchial arch artery (*) in the RFC1 wildtype embryo are shown in (6C); comparable structures labeled in the RFC1 mutant (6D) indicate abnormal vascular morphology. LV: left ventricle.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 79 83 79 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 99 103 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 296 300 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1294 1298 1294 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1493 1495 1493 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
In the present study, microarray analysis of gene expression in whole E9.5 RFC1-/- embryos vs. RFC1+/+ littermates was utilized as a tool for discovering genetic pathways disrupted in the absence of RFC1 that may play a role in the observed developmental anomalies. Our results indicate that RFC1-/- embryos have alterations in the expression of several genes that code for receptors, ligands, interacting proteins, and modifiers of the cubilin-megalin multiligand endocytic receptor complex. Cubilin and megalin are both expressed in the VYS and play a critical role in the maternal-fetal transport of multiple ligands. In the VYS, blood vessels develop adjacent to the VE cell layer, and cell-cell interactions between yolk sac mesenchyme and VE appear to be important for vascular development [45,46]. Cubilin and megalin are cell surface proteins expressed in the extraembryonic VE that work cooperatively to mediate endocytosis of lipoproteins and vitamin complexes (including folate and intrinsic factor-vitamin B12) necessary for erythropoiesis and embryonic development. Uptake of folate and nutrients by the VE may therefore play a role in development of the adjacent yolk sac mesenchyme necessary for formation of the allantois and the initiation of erythropoiesis. In the absence of RFC1, the primary route of folate uptake into cells may be the GPI-anchored folate receptor, or internalization of folate bound to the soluble form of the folate receptor via endocytosis by megalin [28].
###end p 42
###begin p 43
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1 </italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC</italic>
###xml 175 179 175 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 255 259 255 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 561 565 561 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Although our RT-PCR results demonstrated no significant difference in message levels of megalin, a 10-fold increase in Folr1 expression was detected in RFC1-/- relative to RFC+/+ littermates. IHC examination of megalin and Folr1 protein expression in RFC1-/- embryos indicates the disappearance of megalin on the apical cell surface of the VYS, as well as aberrant expression of Folr1, suggesting that, in addition to the absence of RFC1-mediated folate transport, folate uptake via the Folr1-megalin transport pathway may also be compromised in the VYS of RFC1-/- embryos.
###end p 43
###begin p 44
###xml 90 97 90 97 <underline xmlns:xlink="http://www.w3.org/1999/xlink">cubilin</underline>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>cubilin</underline></italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 117 121 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 379 382 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 689 693 689 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
Microarray analysis and RT-PCR validation demonstrated highly significant upregulation of cubilinmessage in E9.5 RFC1-/- embryos. Follow-up IHC analysis suggested a corresponding upregulation in cubilin protein, although technical challenges associated with extracting sufficient amounts of protein from the tiny E9.5 mutant embryos precluded western blot quantification. In RFC1+/+, cubilin protein is observed on the apical surface of neuroepithelial cells, while in mutant embryos, cubilin protein is observed predominantly on the basolateral side of the neuroepithelium. Increased expression of cubilin protein is also widely visible throughout the heart and cranial mesenchyme in RFC1-/- embryos, and is particularly evident in the region surrounding the notochord. It is of interest to note that staining for cubilin remains high on the apical plasma membrane of the VYS in RFC1 mutants, and the polarity of expression does not seem to be altered as it does in the neuroepithelium.
###end p 44
###begin p 45
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 177 181 177 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 586 590 586 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Previous reports suggest that cubilin-mediated endocytosis requires the presence of megalin [47]. If this is the case, even though cubilin is highly expressed in the VYS of RFC1-/- embryos, cubilin-mediated internalization of nutrients in the VYS may be impaired in the absence of megalin, resulting in the observed accumulation of cubilin on the apical surface of the plasma membrane. Defective endocytosis of the cubilin-megalin complex and the observed upregulation in gene expression of transferrin, transthyretin, retinol binding protein, and several of the apolipoproteins in RFC1-/- embryos may reflect a compensatory upregulation in genes encoding for these cubilin-megalin transported ligands, secondary to a perceived deficiency in these nutrients by the developing embryo.
###end p 45
###begin p 46
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amn </italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn </italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn </italic>
###xml 551 555 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amn </italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn </italic>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amn </italic>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amn </italic>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
###xml 918 923 <span type="species:ncbi:10090">mouse</span>
The expression of amn was also significantly upregulated in RFC1-/- embryos.Amn is expressed in the VE, and forms a tight complex with the N-terminal end of cubilin, providing the transmembrane domain necessary for membrane anchoring and endocytic trafficking of cubilin. Amn is therefore an essential component of the cubilin receptor complex, facilitating the endocytosis/transcytosis of cubilin-bound ligands and nutrients that are absorbed from the maternal environment and transported to the developing embryo during gastrulation. Similar to the RFC1-/-, embryonic development is arrested during gastrulation in amn mouse mutants [48-50]. Amn knockout embryos appear abnormal during the early primitive streak stage (E6.5-7.0), and then die between E9.5-E10.5. Mutant embryos are smaller than wildtype littermates, and the embryonic ectoderm is underdeveloped [48]. Depending on the genetic background of the amn mouse mutant, the amniotic membrane may be present [49] or absent [48]. Extra-embryonic structures derived from proximal streak mesoderm (chorion, allantois, yolk sac blood islands), and distal streak mesoderm (notochord, foregut, cardiac mesoderm) in amn mutants appear to develop normally, but embryos have impaired assembly of derivatives of the middle primitive streak, resulting in the absence of paraxial, intermediate and lateral plate mesoderm.
###end p 46
###begin title 47
Dab2
###end title 47
###begin p 48
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1020 1025 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 1228 1233 1228 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1417 1422 1417 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myo6 </italic>
###xml 1470 1474 1470 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1474 1478 1474 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1504 1509 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2 </italic>
###xml 1526 1531 1526 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myo6 </italic>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1645 1647 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1648 1650 1648 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 233 239 <span type="species:ncbi:10090">murine</span>
gene expression was upregulated in our microarray analysis of RFC1-/- embryos, but the difference was not statistically significant on RT-PCR analysis. Dab2 is a cytosolic adapter protein expressed in the VE and VYS. Inactivation of murine Dab2 results in disorganization of the VE layer, and early embryonic lethality prior to gastrulation [51]. Embryos appear to develop normally when Dab2 is conditionally deleted from only the embryo, indicating that Dab2 expression in the VE is the essential component for progression of normal embryogenesis [52]. Dab2 binds to a common sequence in the cytoplasmic tails of lipoprotein receptors [53], and has been found in complexes with megalin in the kidney [54,55], suggesting it may be involved in mediating the intracellular trafficking and/or endocytosis of megalin. The Dab2 gene is alternatively spliced to produce two protein products [56]; expression of the p96 isoform is essential for normal embryonic development and endocytosis of megalin in the VE [57,58]. In p96 Dab2 mutants, megalin and cubilin accumulate at the apical plasma membrane surface, and little intracellular protein or co-localization with early endosome markers is observed. However, if the p67 isoform of Dab2 is inactivated, approximately 50% of homozygotes die by E10.5, and surviving mutants are small and developmentally delayed relative to wildtype littermates [58]. Altered expression of Myo6 was also detected in our microarray analysis of RFC1-/- embryos. Both isoforms of Dab2 bind and recruit Myo6 to clathrin-coated vesicles [52,59], and function in clathrin-mediated endocytosis in polarized epithelial cells [60-62].
###end p 48
###begin title 49
Receptor-associated protein (RAP or Lrpap1)
###end title 49
###begin p 50
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 129 133 129 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1442 1444 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
is another component of the cubilin-megalin multiligand endocytic receptor complex that demonstrated increased expression in RFC1-/- embryos on our microarray analysis, but did not show a statistically significant difference in the RT-PCR analysis. RAP binds both megalin [63] and cubilin [35], and functions as a chaperone-like protein to promote proper folding and protect the ligand binding sites of newly processed low density lipoprotein receptor family proteins, preventing premature interaction of ligands with the receptors [64,65]. Megalin binds to two separate sites on RAP [66] with high affinity, and the binding is calcium-dependent. RAP resides predominantly in the endoplasmic reticulum where it binds and escorts megalin receptors to the golgi. Dissociation of the complex occurs in late endosomes, triggered by the acidic pH of this compartment, and the subsequent protonation of exposed histidine residues on the surface of RAP that modulate the binding/release of RAP from megalin [67]. RAP is subsequently delivered to lysosomes and degraded, while megalin is recycled to the cell surface [68]. RAP deficiency is associated with a decrease in megalin expression and a change in subcellular distribution, causing an accumulation of megalin in intracellular compartments. Homozygous RAP-deficient mice are viable and appear phenotypically normal, although megalin expression in the liver and brain is significantly reduced [69].
###end p 50
###begin p 51
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1305 1310 1305 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
In the renal brush border, megalin has been shown to specifically bind NHE3 [70], a Na+/H+ ion exchanger that mediates the electroneutral exchange of intracellular H+ for extracellular Na+ across plasma membranes. NHE3 plays a critical role in NaCl homeostasis, and the maintenance of intracellular pH, and has also been shown to play a role in clathrin-mediated endocytosis and endosomal acidification [71]. In renal proximal tubule cells, NHE3 deficiency or inhibition reduces the relative cell surface expression of megalin, suggesting intracellular retention of megalin due to impaired trafficking/recycling of endosomes back to the plasma membrane [71]. On our microarray analysis, the gene expression profile of numerous ion channels was altered in RFC1-/-embryos (see supplemental data). RFC1 functions not only in the cellular uptake of folate, but also as a facilitative anion exchanger, and its deletion may impact intracellular pH homeostasis. The association of RAP with megalin is highly pH dependent. Premature dissociation of the RAP-megalin complex could result in misfolding, or early intracellular degradation of megalin along the secretory pathway, which might provide an alternative explanation for the disappearance of megalin protein on the surface of the VYS and neuroepithelium in RFC1 mutants. The absence of cell surface expression of megalin would impact uptake of megalin binding ligands such as transthyretin, hemoglobin, retinol binding protein, apolipoproteins, and shh, and might also impact megalin-dependent endocytosis of the cubilin-binding ligands such as albumin, transferrin, and apolipoprotein A-I. This would result in not only in a folate deficiency, but would also significantly impact maternal-fetal delivery of numerous other nutrients and morphogens required for normal vasculogenesis, hematopoiesis and embryonic development.
###end p 51
###begin title 52
Conclusion
###end title 52
###begin p 53
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1036 1041 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 1078 1097 1078 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cubilin, amnionless</italic>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dab2 </italic>
###xml 1367 1371 1367 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1371 1375 1371 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1432 1433 1432 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1452 1457 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lrp2 </italic>
###xml 1647 1651 1647 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 1651 1655 1651 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1713 1714 1713 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1759 1764 1759 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
RFC1 functions as a facilitative anion exchanger and the primary transporter of reduced folates in multiple tissue types. Polymorphisms in folate transport genes have been implicated as risk factors for certain types of birth defects, and recent evidence from human epidemiological studies demonstrates an association between polymorphisms in RFC1 and increased risk for neural tube defects [72-74], and conotruncal heart defects [75,76]. However, the mechanism(s) by which altered RFC1-mediated folate transport perturb normal morphogenesis are currently unknown. In our knockout mouse model, loss of functional RFC1 during embryogenesis alters the gene expression of numerous transcription factors and ion channels, as well as the expression of a group of genes that code for receptors, ligands and interacting proteins in the cubilin-megalin multiligand endocytic receptor complex. Alterations in the quantity and location of cubilin and megalin protein expression are observed in the yolk sac, neuroepithelium, and mesoderm of E9.5 RFC1 nullizygous mutants. Inactivation of cubilin, amnionless, or dab2 impacts early development, resulting in disorganization of the visceral endoderm, as well as deficiencies in the formation of mesodermal structures, including the chorioallantois, blood islands, and primitive erythrocytes, similar to the phenotype observed in RFC1-/- mutants on low dose maternal folate [see Additional file 2]. Inactivation of lrp2 (megalin) results in multiple malformations later in embryonic/fetal development that include neuroepithelial defects, and craniofacial and lung dysmorphologies similar to those observed in RFC1-/- mutants on high dose maternal folate [see Additional file 2]. The spectrum of malformations observed in RFC1 knockout embryos may therefore be causally related to altered expression of the cubilin-amnionless-megalin complex which mediates the maternal-fetal transport of folate and other nutrients, lipids, and morphogens such as sonic hedgehog (Shh) and retinoids that play critical roles in normal embryogenesis.
###end p 53
###begin title 54
Methods
###end title 54
###begin title 55
Experimental animals
###end title 55
###begin p 56
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc19a1</italic>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
RFC1 knockout mice were generated by targeted inactivation of the RFC1 (Slc19a1) allele as previously described [77]. Following identification of germline chimeras, the mutation was transferred from the hybrid stock genetic background (C57BL/6J) onto an inbred SWV genetic background. RFC/SWV heterozygous mice were housed in microisolator cages, maintained on a 12-hour light/dark cycle, and allowed access to normal Harlan-Teklad (Madison, WI) rodent chow [#8604] and autoclaved water in the AAALAC-accredited University of Nebraska Medical Center (UNMC) laboratory animal facility. All animal procedures were done in accordance with the Public Health Service (PHS) policy on Humane Care and Use of Laboratory Animals, and approved by the UNMC Institutional Animal Care and Use committee. Virgin females 50-70 days of age were mated to males between the hours of 5-10 PM each evening. Females exhibiting vaginal plugs at the end of this period were weighed and housed, up to 5 females per cage, and subsequently placed in treatment groups. The time of conception was considered to be 10 PM on the evening of the mating.
###end p 56
###begin title 57
Folate supplementation
###end title 57
###begin p 58
Folic acid was purchased from Sigma Chemical Co. (St. Louis, MO), and dissolved in nanopure water to make a solution of the desired concentration. Pregnant dams received folic acid (25 mg/kg) by subcutaneous (S.Q.) injection (0.1 ml/10 gm bwt), beginning on E0.5, and continuing daily throughout gestation until the time of sacrifice.
###end p 58
###begin title 59
Fetal collection and morphological staging
###end title 59
###begin p 60
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 536 540 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
At the desired gestational timepoint (E9.5), pregnant RFC1+/- dams were killed by cervical dislocation, the abdomen opened, and the uterine contents removed. The location of all viable fetuses and resorption sites were recorded. Embryos/fetuses were dissected free of the decidual capsule, including its chorion and amnion, and examined for the presence of gross abnormalities. Extraembryonic membranes were collected for genotyping. Whole fetuses were viewed under a Nikon SMZ 1500 stereomicroscope, and photographed using an Optronics(R) (Goleta, CA) camera.
###end p 60
###begin title 61
Tissue preparation
###end title 61
###begin p 62
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 51 55 51 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1</italic>
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
Three separate litters were collected, and one RFC1+/+ and one RFC1-/- embryo from each litter were selected for the microarray experiment. Pregnant dams were sacrificed, and E9.5 RFC1 embryos were quickly removed from the uterus, placed in RNase-free PBS on ice, weighed, snap frozen and stored at -80degreesC until RNA extraction was performed. Extraembryonic membranes were collected for genotyping. Following confirmation of genotype, total RNA was extracted from the embryonic tissue, and provided to the UNMC microarray core facility for further processing.
###end p 62
###begin title 63
RNA isolation
###end title 63
###begin p 64
Total RNA from each whole E9.5 embryo was isolated using the Arcturus (Mountain View, CA) PicoPure kit with an on-column DNAse treatment following a 30 second homogenization using a Kontes Pellet Pestle. Yields of 1.7-39.6 mug of total RNA were obtained, quantitated, and checked on a NanoChip using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) in order to determine sample integrity prior to microarray analysis or QRT-PCR. All RNAs were stored at -80degreesC until downstream analysis was performed. For the microarray experiment, total RNA was reverse-transcribed, and biotin-labeled cRNA probe generated.
###end p 64
###begin title 65
Microarray experiment
###end title 65
###begin p 66
###xml 215 220 <span type="species:ncbi:10090">Mouse</span>
100 ng of total RNA was reverse-transcribed and cRNA generated per Affymetrix instructions using the Affymetrix 2-cycle Target Labeling Kit. Resultant cRNA probes were hybridized to the Affymetrix (Santa Clara, CA) Mouse 430 2.0 genome chip, which profiles the expression of 45,101 unique transcripts. Following washing and staining, the chips were scanned using a GeneChip Scanner 3,000 6 G in the UNMC microarray core facility. Images were analyzed using GCOS imaging software. Quality metric parameters including noise level, background, and the efficiency of reverse transcription were ascertained for all hybridizations. Data sets passing the stringent quality recommendations were normalized using the GCOS software, and the raw intensity values exported for further analysis.
###end p 66
###begin title 67
Statistical analysis
###end title 67
###begin title 68
Microarray data processing
###end title 68
###begin p 69
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rma </italic>
###xml 262 273 262 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Affymetrix </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 774 776 774 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Analyses were conducted with BRB ArrayTools developed by Dr. Richard Simon and Amy Peng. Low-level analysis which converts probe level data to a gene level expression data was done using robust multiarray average (RMA), implemented using the rma function of the Affymetrix package of the Bioconductor project in the R programming language [78-80]. The RMA background correction method corrects the perfect match (PM) probe intensities by using a model based on the assumption that the observed intensities are the sum of signal and noise. Quantile normalization was used to normalize the PM probes and the calculation of summary expression measures was done using the median polish method, which fits a multichip linear model to the data, and gives the expression on the log2 scale. Prior to statistical analysis a filter was applied to reduce the number of genes examined. A gene was excluded unless at least 1 out of the 6 arrays had expression data with a 1.5-fold change or greater in either direction from the gene's median value. This filter reduced the number of transcripts examined to 2982.
###end p 69
###begin title 70
Differential expression
###end title 70
###begin p 71
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
The mice were paired as litter-mates (one wildtype and one nullizygous embryo from each litter) and for each gene, a random-variance paired t-test was conducted to determine if there was a significant difference in expression between the mutant and wild type groups for that gene [81]. P-value adjustment for multiple comparisons was done with the false discovery rate (FDR) method of Benjamini-Hochberg [82]. A significance level of 0.001 for the adjusted univariate test was used to select differentially expressed genes. This reduced the number of probe sets examined to 288.
###end p 71
###begin title 72
Quantitative real-time PCR (qRT-PCR) validation
###end title 72
###begin title 73
First-strand cDNA synthesis
###end title 73
###begin p 74
###xml 228 233 <span type="species:ncbi:10090">Mouse</span>
The SuperScripttrade mark III First-strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) was used to synthesize first-strand cDNA from total RNA. cDNAs were synthesized starting with 300 ng of sample RNAs or 1000 ng of Mouse Universal RNA (MUR, Stratagene, La Jolla, CA) using oligo(dT) primer according to kit directions. cDNAs were stored at -20degreesC. Prior to QRTPCR all cDNAs were diluted with nuclease-free water to 10 ng/ul (based on the amount of input RNA).
###end p 74
###begin title 75
Quantitative RT-PCR
###end title 75
###begin p 76
###xml 832 833 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
###xml 911 916 <span type="species:ncbi:10090">Mouse</span>
###xml 937 942 <span type="species:ncbi:10090">mouse</span>
Quantitative RT-PCR was performed using the Stratagene MX3000P with MxPro v 3.00 software for Comparative Quantitation (Stratagene, La Jolla, CA). The 20 mul reaction consisted of 10 mul 2X TaqMan Universal Master Mix with AmpErase UNG (Applied Biosystems, Foster City, CA), 1 mul of 20X Target Mix [mouse gene-specific primers (forward and reverse), 900 nM final concentration; mouse gene-specific 6-FAM-labeled TaqMan MGB probe at 250 nM final concentration] (Applied Biosystems, Foster City, CA), 1 mul of cDNA, 8 mul nuclease-free water (Ambion, Austin, TX). Controls included no-template controls and "Minus reverse transcriptase" controls. All samples were run in triplicate. Two target genes were used for data normalization: Dctn6 (Dynactin 6) and PPIL2 (peptidylprolyl (cyclophilin)-like isomerase 2). See [Additional file 3] for Genes of Interest (GOI) used in the experiments. A calibrator template, Mouse Universal RNA (from mouse tissues, Stratagene, La Jolla, CA) was also used throughout the course of the assays.
###end p 76
###begin title 77
Statistical analysis of quantitative RT-PCR data
###end title 77
###begin p 78
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
Amplification efficiency curves were generated for each primer/probe set and for each round of cDNA synthesis using 4-fold serial dilutions of mouse universal RNA (Stratagene, La Jolla, CA). Ct values were determined using the MxPro software (Stratagene, La Jolla, CA). Relative levels of mRNA expression in RFC1 nullizygous and wildtype embryos were calculated using the Relative Expression Software Tool (REST v1.9.12) [83]. This software provides proper error propagation and robust statistical analysis by using a random reallocation algorithm with 50,000 iterations. Normalization for each experimental sample used the geometric means of the relative concentration of each normalizer gene (Dctn6 and PPIL 2) [84].
###end p 78
###begin title 79
Ingenuitytrade mark Pathway Analysis
###end title 79
###begin p 80
The list of significantly altered genes identified in the microarray analysis was also examined for the presence of interacting gene networks using Ingenuitytrade mark Pathway Analysis software. A data set containing gene identifiers and their corresponding expression values was uploaded as an Excel spreadsheet using the template provided in the application. Each gene identifier was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. For our data set, the Affymetrix probe set ID was used as an identifier, and an expression value cutoff of 1.5 was set to identify genes whose expression was significantly differentially regulated. These genes were then used as the starting point for generating biological networks. Biological functions were assigned to each gene network by using the findings that have been extracted from the scientific literature and stored in the Ingenuity Pathways Knowledge Base. The biological functions assigned to each network are ranked according to the significance of that biological function to the network. A Fischer's exact test was used to calculate a p-value determining the probability that the biological function assigned to that network is explained by chance alone.
###end p 80
###begin title 81
Immunohistochemistry
###end title 81
###begin p 82
###xml 850 854 849 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 886 890 883 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
The distribution and abundance of cubilin and megalin were characterized immunohistochemically in placentas and embryos collected from control and folic-acid treated dams. Pregnant females were euthanized on E9.5, embryos collected, fixed in fresh 4% paraformaldehyde, paraffin-embedded, and sectioned at 10 mum. Primary antibodies to cubilin and megalin, and FOLR1 were purchased from Santa Cruz Inc., (Santa Cruz, CA). Primary antibody dilutions were optimized at cubilin (1:100), megalin (1:200), and FOLR1 (1:300). Sections were incubated with biotin-conjugated secondary antibody (light microscopy), followed by incubation with streptavidin-HRP, and diaminobenzidine (DAB) solution until brown staining was visible, and counterstained with methyl green. Sections were viewed under a Nikon Eclipse E800 microscope, photographed using an Optronics(R) (Goleta, CA) camera and AnalySIS(R) (Soft Imaging Systems Corp., Lakewood, CA) software, and images processed in Adobe Photoshop.
###end p 82
###begin title 83
List of abbreviations used
###end title 83
###begin p 84
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1:</italic>
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>RFC1:</italic></bold>
###xml 5 31 5 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reduced folate carrier 1; </italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh:</italic>
###xml 31 35 31 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Shh:</italic></bold>
###xml 35 51 35 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sonic hedgehog; </italic>
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Folr1:</italic>
###xml 51 57 51 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Folr1:</italic></bold>
###xml 57 76 57 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">folate receptor 1; </italic>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Timd2:</italic>
###xml 76 82 76 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Timd2:</italic></bold>
###xml 82 135 82 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T-cell immunoglobulin and mucin domain-containing 2; </italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myo6:</italic>
###xml 135 140 135 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Myo6:</italic></bold>
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myosin VI; </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab2:</italic>
###xml 151 156 151 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Dab2:</italic></bold>
###xml 156 176 156 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">disabled homolog 2; </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cubn:</italic>
###xml 176 181 176 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Cubn:</italic></bold>
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cubilin; </italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tf:</italic>
###xml 190 193 190 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Tf:</italic></bold>
###xml 193 206 193 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">transferrin; </italic>
###xml 206 214 206 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LgalS3: </italic>
###xml 206 214 206 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LgalS3: </italic></bold>
###xml 214 255 214 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lectin, galactoside-binding, soluble, 3; </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alb:</italic>
###xml 255 259 255 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Alb:</italic></bold>
###xml 259 268 259 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">albumin; </italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gif:</italic>
###xml 268 272 268 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Gif:</italic></bold>
###xml 272 298 272 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gastric intrinsic factor; </italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amn:</italic>
###xml 298 302 298 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Amn:</italic></bold>
###xml 302 314 302 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amnionless; </italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lrp2:</italic>
###xml 314 319 314 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Lrp2:</italic></bold>
###xml 319 328 319 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">megalin; </italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lrpap1:</italic>
###xml 328 335 328 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Lrpap1:</italic></bold>
###xml 335 384 335 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lipoprotein receptor associated-protein-1 (RAP); </italic>
###xml 384 392 384 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ScgB1A1:</italic>
###xml 384 392 384 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ScgB1A1:</italic></bold>
###xml 392 428 392 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">secretoglobin, family 1A, member 1; </italic>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoA1:</italic>
###xml 428 434 428 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ApoA1:</italic></bold>
###xml 434 453 434 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein A1; </italic>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE:</italic>
###xml 453 458 453 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ApoE:</italic></bold>
###xml 458 476 458 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein E; </italic>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoM:</italic>
###xml 476 481 476 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ApoM:</italic></bold>
###xml 481 499 481 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein M; </italic>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rbp4:</italic>
###xml 499 504 499 504 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Rbp4:</italic></bold>
###xml 504 531 504 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">retinol binding protein 4; </italic>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ttr:</italic>
###xml 531 535 531 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ttr:</italic></bold>
###xml 535 550 535 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">transthyretin; </italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dctn6:</italic>
###xml 550 556 550 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Dctn6:</italic></bold>
###xml 556 568 556 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dynactin 6; </italic>
###xml 568 574 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppil2:</italic>
###xml 568 574 568 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ppil2:</italic></bold>
###xml 574 621 574 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">peptidylprolyl (cyclophilin)-like isomerase 2; </italic>
###xml 621 625 621 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VE: </bold>
###xml 644 649 644 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VYS: </bold>
###xml 668 674 668 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NHE3: </bold>
###xml 696 701 696 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RMA: </bold>
###xml 728 733 728 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FDR: </bold>
###xml 755 761 755 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink">REST: </bold>
###xml 796 801 796 801 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DAB: </bold>
###xml 819 824 819 824 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HRP: </bold>
###xml 824 835 <span type="species:ncbi:3704">horseradish</span>
RFC1:reduced folate carrier 1; Shh:sonic hedgehog; Folr1:folate receptor 1; Timd2:T-cell immunoglobulin and mucin domain-containing 2; Myo6:myosin VI; Dab2:disabled homolog 2; Cubn:cubilin; Tf:transferrin; LgalS3: lectin, galactoside-binding, soluble, 3; Alb:albumin; Gif:gastric intrinsic factor; Amn:amnionless; Lrp2:megalin; Lrpap1:lipoprotein receptor associated-protein-1 (RAP); ScgB1A1:secretoglobin, family 1A, member 1; ApoA1:apolipoprotein A1; ApoE:apolipoprotein E; ApoM:apolipoprotein M; Rbp4:retinol binding protein 4; Ttr:transthyretin; Dctn6:dynactin 6; Ppil2:peptidylprolyl (cyclophilin)-like isomerase 2; VE: visceral endoderm; VYS: visceral yolk sac; NHE3: Na+/H+ ion exchanger; RMA: robust multiarray average; FDR: false discovery rate; REST: Relative Expression Software Tool; DAB: diaminobenzidine; HRP: horseradish peroxidase.
###end p 84
###begin title 85
Authors' contributions
###end title 85
###begin p 86
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
JGvW: experimental design, data interpretation, preparation of figures; writing of manuscript; JM: RNA isolation and preparation of embryo samples for microarray; organization of gene ontology groups (Fig. 1); Ingenuity Pathway analysis (Fig. 2); quantitative RT-PCR validation; LS: statistical analysis of microarray data (Table 1 and supplemental); MvW: statistical analysis of quantitative RT-PCR data (Fig. 4); JW: maintenance of RFC1 mouse colony; timed matings, folate treatments, embryo harvest, graphic design (Fig. 3), photography of immunostained sections (Fig. 5, Fig. 6); JDE: hybridization and scanning of Affymetrix microarray gene chips; LKB: histology, immunohistochemistry; RHF: provided RFC1 knockout mouse model; assisted with writing of manuscript. All authors read and approved the final manuscript.
###end p 86
###begin title 87
Supplementary Material
###end title 87
###begin title 88
Additional file 1
###end title 88
###begin p 89
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
RFC1 microarray gene table. This table provides a complete list of the 200 known genes that were differentially expressed between E9.5 RFC1 nullizygous and wildtype embryos following statistical analysis of the microarray data, including RefSeq transcript ID, gene symbol, description, and fold change for each gene.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 2
###end title 91
###begin p 92
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFC1 </italic>
###xml 267 316 267 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cubilin, amnionless, megalin, Folr1, Dab2, Lrpap1</italic>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Comparison of mouse mutants. This table compares the phenotype of RFC1 nullizygous embryos (on low or high dose maternal folate supplementation) with the phenotype of embryos in which different genes in the cubilin-megalin multiligand endocytic receptor complex (ie. cubilin, amnionless, megalin, Folr1, Dab2, Lrpap1) have been inactivated.
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 3
###end title 94
###begin p 95
Quantitative RT-PCR primer/probe list. This table contains a complete list and details regarding the primers/probes used in the qRT-PCR analysis of genes in the multiligand endocytic receptor complex, as well as details on the function of each gene examined.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Acknowledgements
###end title 97
###begin p 98
This work was supported by NHLBI grant #P01 HL66398, and CoBRE grant #P20 RR018788. The UNMC Microarray Core Facility receives partial support from NIH grant #P20 RR016469 from the INBRE Program of the National Center for Research Resources.
###end p 98
###begin article-title 99
Diagnosis of megaloblastic anaemias
###end article-title 99
###begin article-title 100
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development
###end article-title 100
###begin article-title 101
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Neural and orofacial defects in Folp1 knockout mice [corrected].
###end article-title 101
###begin article-title 102
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Developmental consequences of abnormal folate transport during murine heart morphogenesis
###end article-title 102
###begin article-title 103
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation
###end article-title 103
###begin article-title 104
Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine
###end article-title 104
###begin article-title 105
Vitamin B12-folate interrelationships
###end article-title 105
###begin article-title 106
Membrane transport of folates
###end article-title 106
###begin article-title 107
The kidney in vitamin B12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins
###end article-title 107
###begin article-title 108
Carrier-mediated membrane transport of folates in mammalian cells
###end article-title 108
###begin article-title 109
Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier
###end article-title 109
###begin article-title 110
###xml 64 70 <span type="species:ncbi:9986">rabbit</span>
The transmembrane pH gradient drives uphill folate transport in rabbit jejunum. Direct evidence for folate/hydroxyl exchange in brush border membrane vesicles
###end article-title 110
###begin article-title 111
Role of reduced folate carrier in intestinal folate uptake
###end article-title 111
###begin article-title 112
Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart
###end article-title 112
###begin article-title 113
###xml 20 26 <span type="species:ncbi:10090">murine</span>
Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis
###end article-title 113
###begin article-title 114
###xml 61 66 <span type="species:ncbi:10090">Mouse</span>
Embryonic Development in the Reduced Folate Carrier Knockout Mouse Is Modulated by Maternal Folate Supplementation
###end article-title 114
###begin article-title 115
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs
###end article-title 115
###begin article-title 116
National Center for Biotechnology Information. Data series GSE10659. Gene Expression Omnibus,
###end article-title 116
###begin article-title 117
Megalin and cubilin: multifunctional endocytic receptors
###end article-title 117
###begin article-title 118
Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia
###end article-title 118
###begin article-title 119
New insights into carrier binding and epithelial uptake of the erythropoietic nutrients cobalamin and folate
###end article-title 119
###begin article-title 120
Overlapping expression patterns of the multiligand endocytic receptors cubilin and megalin in the CNS, sensory organs and developing epithelia of the rodent embryo
###end article-title 120
###begin article-title 121
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Differential distribution of cubilin and megalin expression in the mouse embryo
###end article-title 121
###begin article-title 122
The role of megalin (LRP-2/Gp330) during development
###end article-title 122
###begin article-title 123
Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis
###end article-title 123
###begin article-title 124
Cubilin and megalin: partners in lipoprotein and vitamin metabolism
###end article-title 124
###begin article-title 125
Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B(12)
###end article-title 125
###begin article-title 126
Megalin binds and mediates cellular internalization of folate binding protein
###end article-title 126
###begin article-title 127
Epithelial Trafficking of Sonic Hedgehog by Megalin
###end article-title 127
###begin article-title 128
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Defective forebrain development in mice lacking gp330/megalin
###end article-title 128
###begin article-title 129
LRP2/megalin is required for patterning of the ventral telencephalon
###end article-title 129
###begin article-title 130
Megalin functions as an endocytic sonic hedgehog receptor
###end article-title 130
###begin article-title 131
Expression and role of cubilin in the internalization of nutrients during the peri-implantation development of the rodent embryo
###end article-title 131
###begin article-title 132
The intrinsic factor-vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins
###end article-title 132
###begin article-title 133
Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding
###end article-title 133
###begin article-title 134
The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless
###end article-title 134
###begin article-title 135
Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies
###end article-title 135
###begin article-title 136
Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation
###end article-title 136
###begin article-title 137
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse amnionless, which is required for primitive streak assembly, mediates cell-surface localization and endocytic function of cubilin on visceral endoderm and kidney proximal tubules
###end article-title 137
###begin article-title 138
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Distinct roles for visceral endoderm during embryonic mouse development
###end article-title 138
###begin article-title 139
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo
###end article-title 139
###begin article-title 140
Axis development and early asymmetry in mammals
###end article-title 140
###begin article-title 141
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Lineage development and polar asymmetries in the peri-implantation mouse blastocyst
###end article-title 141
###begin article-title 142
Implantation and the placenta: key pieces of the development puzzle
###end article-title 142
###begin article-title 143
Molecular regulation of embryonic hematopoiesis and vascular development: a novel pathway
###end article-title 143
###begin article-title 144
###xml 50 56 <span type="species:ncbi:10090">murine</span>
Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants
###end article-title 144
###begin article-title 145
Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia
###end article-title 145
###begin article-title 146
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
A candidate gene for the amnionless gastrulation stage mouse mutation encodes a TRAF-related protein
###end article-title 146
###begin article-title 147
The amn gene product is required in extraembryonic tissues for the generation of middle primitive streak derivatives
###end article-title 147
###begin article-title 148
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
The amnionless gene, essential for mouse gastrulation, encodes a visceral-endoderm-specific protein with an extracellular cysteine-rich domain
###end article-title 148
###begin article-title 149
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis
###end article-title 149
###begin article-title 150
Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton
###end article-title 150
###begin article-title 151
Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2
###end article-title 151
###begin article-title 152
Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin
###end article-title 152
###begin article-title 153
Mutually dependent localization of megalin and Dab2 in the renal proximal tubule
###end article-title 153
###begin article-title 154
###xml 100 110 <span type="species:ncbi:7227">Drosophila</span>
Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product
###end article-title 154
###begin article-title 155
Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor
###end article-title 155
###begin article-title 156
Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein
###end article-title 156
###begin article-title 157
DOC-2/DAB2 is the binding partner of myosin VI
###end article-title 157
###begin article-title 158
Myosin VI isoform localized to clathrin-coated vesicles with a role in clathrin-mediated endocytosis
###end article-title 158
###begin article-title 159
Regulation of myosin-VI targeting to endocytic compartments
###end article-title 159
###begin article-title 160
Myosin VI: two distinct roles in endocytosis
###end article-title 160
###begin article-title 161
Functional domains of the receptor-associated protein (RAP)
###end article-title 161
###begin article-title 162
Role of rap in the biogenesis of lipoprotein receptors
###end article-title 162
###begin article-title 163
The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family
###end article-title 163
###begin article-title 164
Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions
###end article-title 164
###begin article-title 165
RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi
###end article-title 165
###begin article-title 166
Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes
###end article-title 166
###begin article-title 167
Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo
###end article-title 167
###begin article-title 168
Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule
###end article-title 168
###begin article-title 169
NHE3 serves as a molecular tool for cAMP-mediated regulation of receptor-mediated endocytosis
###end article-title 169
###begin article-title 170
###xml 60 66 <span type="species:ncbi:9606">infant</span>
Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida
###end article-title 170
###begin article-title 171
Polymorphisms in genes involved in folate metabolism as risk factors for NTDs
###end article-title 171
###begin article-title 172
[Epidemiological study on reduced folate carrier gene(RFC1 A80G) polymorphism and other risk factors of neural tube defects]
###end article-title 172
###begin article-title 173
###xml 21 27 <span type="species:ncbi:9606">infant</span>
Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China
###end article-title 173
###begin article-title 174
###xml 21 27 <span type="species:ncbi:9606">infant</span>
Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects
###end article-title 174
###begin article-title 175
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis
###end article-title 175
###begin article-title 176
An R package for analyses of Affymetrix oligonucleotide arrays
###end article-title 176
###begin article-title 177
Affy: Methods for Affymetrix Oligonucleotide Arrays. R package version 1.5.8
###end article-title 177
###begin article-title 178
A random variance model for detection of differential gene expression in small microarray experiments
###end article-title 178
###begin article-title 179
Controlling the false discovery rate: a practical and powerful approach to multiple testing.
###end article-title 179
###begin article-title 180
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
###end article-title 180
###begin article-title 181
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
###end article-title 181

